Results for this period
Full year1 June 2025 to 31 May 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Sales of the 生漢煎 herbal medicine series, revisions to SOKUYAKU system usage fees and the accumulation of usage volume, branding support, sales promotion support and BPO services in the healthcare marketing business, and the completion of highly profitable projects in the logistics business.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2025 to 31 May 2026 |
| Net Sales | ¥22,235 million (YoY +3.4%) |
| Operating profit | ¥312 million (YoY +6.3%) |
| Ordinary income | ¥415 million (YoY +79.3%) |
| Profit attributable to owners of the parent | ¥-321 million |
| Net income per share | -¥60.64 |
| Operating Margin | 1.4% |
| Equity ratio | End of the current fiscal period 12.8 / End of previous period 15.3 |
| Total assets | ¥9,585 million |
| Net assets | ¥1,534 million |
| Cash flows from operating activities | ¥454 million |
| Cash flows from investing activities | ¥-1,190 million |
| Cash flows from financing activities | ¥758 million |
| Cash and cash equivalents at end of period | ¥2,131 million |
| Full-year earnings forecast | Net Sales ¥26,500 million (YoY +19.2%) / Operating profit ¥1,050 million (YoY +236.2%) / Ordinary income ¥1,000 million (YoY +140.9%) / Net income ¥550 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Medical Care Sales business ¥5,283.80 thousand (YoY -7.9%), Healthcare Sales business ¥5,383.86 thousand (YoY -11.5%), Healthcare Marketing business ¥11,568.33 thousand (YoY +19.4%) |
| Segment profit | Medical Care Sales business ¥483,550 thousand (YoY -4.7%), Healthcare Sales business ¥-44,552 thousand, Healthcare Marketing business ¥236,800 thousand (YoY +86.2%) |
| Depreciation and amortization | ¥37,404 thousand |
| Impairment loss | ¥44,190 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥669 thousand, Gain on reversal of subscription rights to shares ¥135 thousand / Extraordinary loss Impairment Losses ¥44,190 thousand, Amortization of goodwill ¥435,241 thousand, Impairment Loss on Investment Securities ¥37,050 thousand, Other ¥143 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社shake-hands / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 5,336,369 |
| Treasury Shares at Period-End | 149 |
| Factors Behind Changes in Business Performance | Sales of the 生漢煎 herbal medicine series, revisions to SOKUYAKU system usage fees and the accumulation of usage volume, branding support, sales promotion support and BPO services in the healthcare marketing business, and the completion of highly profitable projects in the logistics business. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the healthcare marketing business, branding support, sales promotion support, BPO services and the completion of highly profitable logistics projects contributed to earnings. At SOKUYAKU, average revenue per user and profitability improved following a revision to system usage fees, while the company recorded extraordinary losses including ¥435,241 thousand in goodwill amortization and ¥44,190 thousand in impairment losses.